Results

Total Results: 463 records

Showing results for "breast cancer".

201. Sixth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/reports-congress/sixth-annual-report-congress-high-priority-evidence-gaps-clinical-preventive-services
     December 01, 2017 - prevent it from making recommendations for specific populations or age groups, such as screening for breast … cancer in African American women. … Evidence Gaps Relating to Specific Populations That Deserve Further Research: Screening for Breast … Cancer in African American Women Screening for Cervical Cancer in Hispanic and African American Women

202. Clinical Summary: Screening for Ovarian Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/gGt88ZDJVoaNx_UZ-yMnyk
     February 06, 2018 - Women with a family history of ovarian or breast cancer may be at risk for a hereditary cancer syndrome

203. Pruebas de Detección del Cáncer de Mama, Hablémoslo (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2024-04/breast-cancer-screening-lets-talk-about-final-rec-spanish-discussion-guide.pdf
     January 01, 2024 - https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening https://www.uspreventiveservicestaskforce.org … brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction … www.uspreventiveservicestaskforce.org/apps/ Acrobat Accessibility Report Accessibility Report Filename: 15497-Breast-Cancer-Lets-Talk-About-It-V4

204. Second Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2012%20(2).pdf
     November 01, 2012 - Breast cancer: Screening With mammography in Women ages 50 to 74 years* The USPSTF recommends biennial … D Breast cancer: Preventive medication for Women at average risk The USPSTF recommends against routine … use of tamoxifen or raloxifene for the primary prevention of breast cancer in women at low or average … risk for breast cancer. … Breast cancer: Screening With mammography in Women 75 and Older* The USPSTF concludes that the current

205. Clinical Summary: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/kQWppPe7wLrdrHnbqM2BQu
     December 05, 2017 - USPSTF recommends offering medications such as tamoxifen and raloxifene to women at increased risk of breast … cancer who do not have contraindications and are at low risk of adverse medication effects to decrease … the risk of breast cancer.

206. Information for Consumers | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/information-for-consumers
     Prevention in Adults: Behavioral Counseling, 2012 Breast … Cancer: Information for Patients National Cancer Institute … Guide Breast Cancer: Screening Caries dentales

207. Hablemos: Medicamentos para ayudar a prevenir el cáncer de mama (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/lets-talk-about-it-breast-cancer-prevention-medications-spanish_0.pdf
     December 19, 2022 - Preventivos de los Estados Unidos tiene una recomendación sobre este tema (Medication Use to Reduce Risk of Breast … Cancer [Uso de medicamentos para reducir el riesgo de tener cáncer de mama]). … sobre la detección del cáncer de mama y la prevención del cáncer relacionada con el cáncer de mama (Breast … Cancer, BRCA).

208. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfannrpt2011.pdf
     January 01, 2012 - B Breast Cancer: Preventive Medication Discussion With Women at Increased Risk The USPSTF recommends … that clinicians discuss chemoprevention with women at high risk for breast cancer and at low risk … D Breast Cancer: Preventive Medication for Women at Average Risk The USPSTF recommends against routine … use of tamoxifen or raloxifene for the primary prevention of breast cancer in women at low or average … risk for breast cancer.

209. Individualizing Cancer Screening in Older Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/individualizing-cancer-screening-older-adults
     March 01, 2021 - cancer.” … Caregivers' views on appropriate treatment of breast cancer varied widely, except in the case of severe … Mathieu and colleagues developed a decision aid outlining potential risks of breast cancer screening … Screening for breast cancer: an update for the U.S. Preventive Services Task Force.  … Current practices and perspectives on breast cancer screening and treatment in older women with dementia

210. Archived: Vitamin Supplementation to Prevent Cancer and CVD: Counseling and Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication
     June 15, 2003 - cancer. 10 , 11 Despite efforts to adjust for confounding variables, the observational, non-random … shown no significant association between vitamin E supplement use and the risk for prostate, lung, or breast … Intake of vitamins A,C, and E and postmenopausal breast cancer. The Iowa Women's Health Study. … Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. … A prospective study of the intake of vitamins C, E and A and the risk of breast cancer.

211. Archived: Vitamin Supplementation to Prevent Cancer and CVD: Counseling and Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication-2003
     June 15, 2003 - cancer. 10 , 11 Despite efforts to adjust for confounding variables, the observational, non-random … shown no significant association between vitamin E supplement use and the risk for prostate, lung, or breast … Intake of vitamins A,C, and E and postmenopausal breast cancer. The Iowa Women's Health Study. … Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. … A prospective study of the intake of vitamins C, E and A and the risk of breast cancer.

212. Routine Vitamin Supplementation to U.S. Preventive Services Task Force - Recommendations and Rationale (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/8VDGX2azX2-s7FfxDeKMPN
     June 01, 2003 - cancer.10,11 Despite efforts to adjust for confounding variables, the observational, non-random design … shown no significant association between vitamin E supplement use and the risk for prostate, lung, or breast … Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. … A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. … Intake of vitamins A,C, and E and postmenopausal breast cancer. The Iowa Women’s Health Study.

213. Draft Research Plan: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/brca-related-cancer-risk-assessment-genetic-counseling-testing
     January 18, 2024 - significant pathogenic mutations in the BRCA1 and BRCA2 genes associated with increased risk for breast … cancer, ovarian cancer, or both. † Includes women who may have a previous diagnosis of breast or ovarian

214. Task Force Resources | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/task-force-resources
     May 04, 2025 - and explains who should be screened for HIV and who should be offered PrEP Medicines to Help Prevent Breast … Cancer Discussion Guide for Healthcare Providers and Patients PDF, 147 KB (Also available in Spanish … discussions between healthcare professionals and their patients about medicines that can help reduce breast … cancer risk among women who are at high risk Let's Talk About It: Starting Aspirin to Prevent Heart

215. Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/zHvENvrSUeZh6gFPUK_37c
     February 13, 2018 - cancer may be at risk for a hereditary cancer syn- drome and should discuss their family history with … Women with a family history of ovarian or breast cancer may be at risk for a hereditary cancer syndrome … and 1.6% reported a ma- ternal history of ovarian cancer and 6.4% reported a maternal his- tory of breast … cancer; however, women with a family history con- sidered “high risk” for familial ovarian cancer were … Women with a family his- tory of ovarian or breast cancer or symptoms should discuss this with their

216. Evidence Summary: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary28/menopausal-hormone-therapy-preventive-medication
     November 01, 2022 - Risks, per 10,000 persons, were significantly increased for invasive breast cancer (242 vs 191 cases; … breast cancer remained statistically significantly increased during 19.4 years of cumulative (trial … Breast cancer and menopausal hormone therapy by race/ethnicity and body mass index. … Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. … Hormone replacement therapy, family history, and breast cancer risk among postmenopausal women.

217. Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication
     December 12, 2017 - Risks, per 10,000 person-years, were significantly increased for invasive breast cancer (9 more cases … In the WHI (n = 10,739), estrogen alone produced a nonsignificant decrease in invasive breast cancer … cancer (9 more cases per 10,000 person-years [95% CI, 1 to 19]). 15 The risk of invasive breast cancer … Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. … Hormone replacement therapy, family history, and breast cancer risk among postmenopausal women.

218. Archived: Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication-december-2017
     December 12, 2017 - Risks, per 10,000 person-years, were significantly increased for invasive breast cancer (9 more cases … In the WHI (n = 10,739), estrogen alone produced a nonsignificant decrease in invasive breast cancer … cancer (9 more cases per 10,000 person-years [95% CI, 1 to 19]). 15 The risk of invasive breast cancer … Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. … Hormone replacement therapy, family history, and breast cancer risk among postmenopausal women.

219. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(6).pdf
     November 01, 2014 - For women who are at increased risk for breast cancer and at low risk for adverse medication effects … D Breast Cancer: Preventive Medication for Women Not at Increased Risk The USPSTF recommends against … cancer in women who are not at increased risk for breast cancer. … D Breast Cancer: Teaching Breast Self-Examination* The USPSTF recommends against teaching breast … I Breast Cancer: Screening With Clinical Breast Examination in Women Age 40 Years and Older* The

220. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
     November 01, 2014 - For women who are at increased risk for breast cancer and at low risk for adverse medication effects … D Breast Cancer: Preventive Medication for Women Not at Increased Risk The USPSTF recommends against … cancer in women who are not at increased risk for breast cancer. … D Breast Cancer: Teaching Breast Self-Examination* The USPSTF recommends against teaching breast … I Breast Cancer: Screening With Clinical Breast Examination in Women Age 40 Years and Older* The